A Study of APX3330 in Patients With Advanced Solid Tumors
Clinical trial NCT03375086 · COMPLETED
Trial details
- NCT number
- NCT03375086
- Sponsor
- Apexian Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-30
- Primary completion
- 2018-08-18
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.